Results 21 to 30 of about 2,606,922 (264)
Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status. [PDF]
, 2017 Antihypertensive monotherapy is often insufficient to control blood pressure (BP). Several recent guidelines advocate for initial combination drug therapy in many patients. This meta-analysis of seven randomized, double-blind studies (N = 5888) evaluated
Bakris, George +3 more
core +1 more source
Combination therapy of hypertension
Медицинский совет, 2015 The article is a short overview of articles related to the prescription of combination antihypertensive therapy. The focus is on the evidence of administration of a fixed combination - lercanidipine plus enalapril, which is characterized by a high ...
O. O. Bolshakova
doaj +1 more source
Combination Therapy of Sorafenib and Transarterial Chemoembolization in Management of Hepatoma [PDF]
, 2013 Incidence of hepatocellular carcinoma (HCC) continues to increase in developing countries and rank 5th in male and 7th in female. Main cause being reported is chronic hepatitis B in Asian region. Treatment of choice for HCC is liver resection, however it
Gani, R. A. (Rino) +3 more
core +1 more source
Combination Therapy for Myelomatosis [PDF]
BMJ, 1974 Twenty-eight patients with multiple myeloma have been treated with a quadruple chemotherapeutic regimen consisting of 1, 3 bis (2-chloroethyl)-1-nitrosourea (BCNU), cyclophosphamide, melphalan, and prednisolone. Nineteen new patients and nine who had escaped from previous single-agent therapy were included in the study.
I. W. Delamore, L. Azam
openaire +3 more sources
Combination therapy for hypertension
South African Family Practice, 2005 No abstract available.
J.A. Ker
doaj +1 more source
MTOR cross-talk in cancer and potential for combination therapy [PDF]
, 2018 The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating a variety of exogenous cues to regulate cellular growth and metabolism, in both physiological and pathological conditions.
Bazzichetto, C. +7 more
core +3 more sources
Combination therapy in hypertension
South African Family Practice, 2007 Hypertension is one of the most important risk factors for death, heart failure, ischaemic heart disease, stroke and chronic kidney disease. Treatment of hypertension to particularly to goal blood pressure (BP) prevents these complications.
Brian Rayner
doaj +1 more source
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda [PDF]
, 2011 Little is known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan ...
Bakanda, Celestin +8 more
core +2 more sources
Combination Antithrombotic Therapies [PDF]
Circulation, 2010 Atherothrombosis is the major pathophysiological process responsible for the occurrence of severe ischemic events in patients with cardiovascular diseases. In the United States, atherothrombosis strongly influenced mortality in 2004: One in 2.8 deaths was due to CVD, 1 in 5 deaths to coronary heart disease, and 1 in 17 deaths to stroke.1 Because ...
Paul A. Gurbel, Udaya S. Tantry
openaire +3 more sources
Efficacy of Elaborated Semantic Features Analysis in Aphasia: a quasi-randomised controlled trial [PDF]
, 2019 Background: Word finding difficulty is one of the most common features of aphasia. Semantic Features Analysis (SFA) directly aims to improve word finding in people with aphasia.
Elman R. +13 more
core +1 more source